Edap Tms Stock

Edap Tms OCF Margin

The Operating Cash Flow Margin of Edap Tms (EDAP) as of Jul 26, 2026 is -23.19 %. In the previous year, Operating Cash Flow Margin was -21.19 % — a change of 9.48% (lower).

OCF Margin

-23.19 %

YoY

9.48%

Last updated:

Operating Cash Flow Margin of Edap Tms is 2026 -23.19 % . Operating Cash Flow Margin of Edap Tms was 2025 -21.19 % . It decreases by 9.48% lower compared to the previous year.
Access this data via the Eulerpool API

Edap Tms Stock analysis

What does Edap Tms do? Edap Tms SA is a French company specialized in the development and marketing of medical devices. The company was founded in 1979 and has its headquarters in Vaulx-en-Velin, France. With over 300 employees, Edap Tms SA operates worldwide and has branches in the USA, Asia, and Europe. The company's business model is based on the development of non-invasive medical devices, particularly HIFU (High-Intensity Focused Ultrasound) devices. With its technology, the company has developed a revolutionary new procedure for tumor treatment that can replace traditional radiation therapy. HIFU offers a gentler and more precise alternative for tumor treatment without damaging the surrounding tissue. Edap Tms SA offers its products and services in four main business areas: 1. HIFU systems for the treatment of prostate cancer: Edap Tms SA has developed a HIFU system capable of treating prostate cancer without invasive procedures. The system uses a special ultrasound probe inserted into the rectum to locate the tumor and direct targeted sound waves at the tumor, destroying cancer cells. 2. HIFU systems for the treatment of kidney cancer: Edap Tms SA has also developed a HIFU system capable of treating kidney cancer tumors. It works similarly to the prostate cancer system, effectively destroying the tumor through targeted sound waves. 3. Mobile HIFU devices: Edap Tms SA has developed mobile HIFU devices suitable for use in hospitals and clinics. These devices can be quickly and easily transported from room to room, allowing medical professionals to perform HIFU treatments without the need for additional equipment. 4. Bladder cancer treatment technology: Edap Tms SA has also developed technology used in the treatment of bladder cancer. The system also utilizes HIFU technology to destroy tumor cells, but it is introduced through the urethra and focuses on the tumor in the bladder. Edap Tms SA is a global leader in the development and marketing of HIFU systems. The company aims to improve cancer treatment and provide patients with a more effective and gentler alternative to traditional radiation therapy. With a wide range of products suitable for various types of cancer and a strong presence in the USA, Europe, and Asia, Edap Tms SA is a highly regarded brand in the medical device field. Overall, Edap Tms SA is a company with a rich history that focuses on innovative technologies and continuously strives to improve the lives of cancer patients. With its HIFU portfolio and strong market presence, the company is on track to achieve its goals and solidify its position as one of the leading providers of medical devices worldwide. Edap Tms is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Edap Tms stock

Operating Cash Flow Margin of Edap Tms is -23.19 % in 2026.

Access this data via the Eulerpool API

Margins — Edap Tms

All Key Metrics — Edap Tms